GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PureTech Health PLC (LSE:PRTC) » Definitions » Cash Flow from Investing

PureTech Health (LSE:PRTC) Cash Flow from Investing : £54.85 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is PureTech Health Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the six months ended in Dec. 2023, PureTech Health spent £0.00 Mil on purchasing property, plant, equipment. It gained £0.22 Mil from selling property, plant, and equipment. It spent £0.00 Mil on purchasing business. It gained £0.00 Mil from selling business. It spent £142.48 Mil on purchasing investments. It gained £59.54 Mil from selling investments. It paid £0.00Mil for net Intangibles purchase and sale. And it paid £0.14 Mil for other investing activities. In all, PureTech Health spent £82.87 Mil on investment activities in financial market and operating subsidiaries for the six months ended in Dec. 2023.


PureTech Health Cash Flow from Investing Historical Data

The historical data trend for PureTech Health's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PureTech Health Cash Flow from Investing Chart

PureTech Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.57 271.17 148.43 -88.03 54.50

PureTech Health Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.97 -5.59 -82.38 137.72 -82.87

PureTech Health Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

PureTech Health's Cash Flow from Investing for the fiscal year that ended in Dec. 2023 is calculated as:

PureTech Health's Cash Flow from Investing for the quarter that ended in Dec. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £54.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PureTech Health  (LSE:PRTC) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

PureTech Health's purchase of property, plant, equipment for the six months ended in Dec. 2023 was £0.00 Mil. It means PureTech Health spent £0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

PureTech Health's sale of property, plant, equipment for the six months ended in Dec. 2023 was £0.22 Mil. It means PureTech Health gained £0.22 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

PureTech Health's purchase of business for the six months ended in Dec. 2023 was £0.00 Mil. It means PureTech Health spent £0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

PureTech Health's sale of business for the six months ended in Dec. 2023 was £0.00 Mil. It means PureTech Health gained £0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

PureTech Health's purchase of investment for the six months ended in Dec. 2023 was £-142.48 Mil. It means PureTech Health spent {stock_data.stock.currency_symbol}}142.48 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

PureTech Health's sale of investment for the six months ended in Dec. 2023 was £59.54 Mil. It means PureTech Health gained £59.54 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

PureTech Health's net Intangibles purchase and sale for the six months ended in Dec. 2023 was £0.00 Mil. It means PureTech Health paid £0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

PureTech Health's cash from discontinued investing activities for the six months ended in Dec. 2023 was 0.00 Mil. It means PureTech Health paid £0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

PureTech Health's cash from other investing activities for the six months ended in Dec. 2023 was £-0.14 Mil. It means PureTech Health paid £0.14 Mil for other investing activities.


PureTech Health Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of PureTech Health's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


PureTech Health (LSE:PRTC) Business Description

Traded in Other Exchanges
Address
6 Tide Street, Suite 400, Boston, MA, USA, 02210
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.